Naproxen
- Product NDC
- 68071-2793
- 11-digit product format
- 680712793
- Labeler code
- 68071
- Product ID
- 68071-2793_e3c896c5-52d8-7771-e053-2995a90a30db
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA212517
- Marketing category
- ANDA
- Marketing start
- 2020-03-01
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 250 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-2793-6 | Naproxen | 6 in 1 BOTTLE | TABLET | 6 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-2793 | NAPROXEN TABLET [NUCARE PHARMACEUTICALS,INC.] | 1 | Legacy NDC, 1 package rows | 20220716_e3c896c5-52d7-7771-e053-2995a90a30db.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-2793-6 | 68071279306 | 6 TABLET in 1 BOTTLE (68071-2793-6) | 6 tablet | 2022-07-14 | 0000-00-00 | No | No | Current |